Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Teekay Tankers | TNK | Oct 31, 2024 | 47.68 | -0.36 |
TEGNA | TGNA | Oct 31, 2024 | 16.43 | -1.50 |
Tejon Ranch | TRC | Oct 31, 2024 | 15.91 | -1.43 |
Tekla Healthcare Investors | HQH | Oct 31, 2024 | 18.03 | -0.72 |
TELA Bio | TELA | Oct 31, 2024 | 2.81 | -1.06 |
Teladoc Health | TDOC | Oct 31, 2024 | 9.00 | +1.58 |
Telecom Argentina ADR | TEO | Oct 31, 2024 | 9.28 | +3.23 |
Telecom Services ETF Vanguard | VOX | Oct 31, 2024 | 148.32 | -1.15 |
Teledyne Technologies | TDY | Oct 31, 2024 | 455.32 | -1.34 |
Teleflex | TFX | Oct 31, 2024 | 201.06 | -14.52 |
Telefonica ADR | TEF | Oct 31, 2024 | 4.63 | -0.64 |
Telefonica Brasil ADR | VIV | Oct 31, 2024 | 9.11 | 0.00 |
Telephone And Data Systems | TDS | Oct 31, 2024 | 29.75 | +0.47 |
Telephone And Data Systems Pref | TDS-U | Oct 31, 2024 | 20.58 | -2.65 |
Telephone And Data Systems VV Pref | TDS-V | Oct 31, 2024 | 18.74 | -2.24 |
Telesat | TSAT | Oct 31, 2024 | 13.09 | +3.56 |
Tellurian | TELL | Oct 31, 2024 | 1.00 | 0.00 |
Telomir Pharmaceuticals | TELO | Oct 31, 2024 | 4.06 | -7.94 |
Telos | TLS | Oct 31, 2024 | 3.51 | -5.90 |
Telus | TU | Oct 31, 2024 | 15.81 | -0.69 |
Telus International | TIXT | Oct 31, 2024 | 3.79 | -0.52 |
Tempest Therapeutics | TPST | Oct 31, 2024 | 0.92 | -4.44 |
Templeton Dragon Fund | TDF | Oct 31, 2024 | 8.86 | -0.45 |
Templeton Emerging Markets | TEI | Oct 31, 2024 | 5.46 | -0.55 |
Templeton Emerging Markets Fund | EMF | Oct 31, 2024 | 12.94 | -0.69 |
Tempur Sealy International | TPX | Oct 31, 2024 | 47.91 | -1.92 |
Tempus AI | TEM | Oct 31, 2024 | 44.62 | -1.96 |
Tenable | TENB | Oct 31, 2024 | 39.61 | -3.93 |
Tenaris ADR | TS | Oct 31, 2024 | 32.88 | +0.61 |
Tenax Therapeutics | TENX | Oct 31, 2024 | 4.39 | +2.09 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.